| Treating rheumatoid arthritis to target: recommendations of an international task force JS Smolen, D Aletaha, JWJ Bijlsma, FC Breedveld, D Boumpas, ... Annals of the rheumatic diseases 69 (4), 631-637, 2010 | 2935 | 2010 |
| Prevalence of comorbidities in rheumatoid arthritis and evaluation of their monitoring: results of an international, cross-sectional study (COMORA) M Dougados, M Soubrier, A Antunez, P Balint, A Balsa, MH Buch, ... Annals of the rheumatic diseases 73 (1), 62-68, 2014 | 1040 | 2014 |
| EULAR Sjogren's syndrome disease activity index: development of a consensus systemic disease activity index for primary Sjogren's syndrome R Seror, P Ravaud, SJ Bowman, G Baron, A Tzioufas, E Theander Ann Rheum Dis. 69 (6), 1103, 2010 | 1011 | 2010 |
| Mapping and predicting mortality from systemic sclerosis M Elhai, C Meune, M Boubaya, J Avouac, E Hachulla, A Balbir-Gurman, ... Annals of the rheumatic diseases 76 (11), 1897-1905, 2017 | 587 | 2017 |
| Clinical course of COVID-19 in a series of patients with chronic arthritis treated with immunosuppressive targeted therapies S Monti, S Balduzzi, P Delvino, E Bellis, VS Quadrelli, C Montecucco Annals of the rheumatic diseases 79 (5), 667-668, 2020 | 531 | 2020 |
| Ultrasonographic evaluation of joint involvement in early rheumatoid arthritis in clinical remission: power Doppler signal predicts short-term relapse CA Scire, C Montecucco, V Codullo, O Epis, M Todoerti, R Caporali Rheumatology 48 (9), 1092-1097, 2009 | 425 | 2009 |
| Multinational evidence-based recommendations for the diagnosis and management of gout: integrating systematic literature review and expert opinion of a broad panel of … F Sivera, M Andrés, L Carmona, ASR Kydd, J Moi, R Seth, ... Annals of the rheumatic diseases 73 (2), 328-335, 2014 | 406 | 2014 |
| Evidence for treating rheumatoid arthritis to target: results of a systematic literature search M Schoels, R Knevel, D Aletaha, JWJ Bijlsma, FC Breedveld, ... Annals of the rheumatic diseases 69 (4), 638-643, 2010 | 363 | 2010 |
| Adalimumab alone and in combination with disease-modifying antirheumatic drugs for the treatment of rheumatoid arthritis in clinical practice: the Research in Active Rheumatoid … GR Burmester, X Mariette, C Montecucco, I Monteagudo-Sáez, M Malaise, ... Annals of the rheumatic diseases 66 (6), 732-739, 2007 | 297 | 2007 |
| Prevalence of comorbidities and evaluation of their screening in spondyloarthritis: results of the international cross-sectional ASAS-COMOSPA study A Moltó, A Etcheto, D Van Der Heijde, R Landewé, F Van Den Bosch, ... Annals of the rheumatic diseases 75 (6), 1016-1023, 2016 | 296 | 2016 |
| Systematic microanatomical analysis of CXCL13 and CCL21 in situ production and progressive lymphoid organization in rheumatoid synovitis A Manzo, S Paoletti, M Carulli, MC Blades, F Barone, G Yanni, ... European journal of immunology 35 (5), 1347-1359, 2005 | 289 | 2005 |
| Prednisone plus methotrexate for polymyalgia rheumatica: a randomized, double-blind, placebo-controlled trial R Caporali, MA Cimmino, G Ferraccioli, R Gerli, C Klersy, C Salvarani, ... Annals of Internal Medicine 141 (7), 493-500, 2004 | 287 | 2004 |
| Recommendations for the management of mixed cryoglobulinemia syndrome in hepatitis C virus-infected patients M Pietrogrande, S De Vita, AL Zignego, P Pioltelli, D Sansonno, S Sollima, ... Autoimmunity reviews 10 (8), 444-454, 2011 | 251 | 2011 |
| Comparison of clinical versus ultrasound‐determined synovitis in juvenile idiopathic arthritis S Magni‐Manzoni, O Epis, A Ravelli, C Klersy, C Veisconti, S Lanni, ... Arthritis Care & Research: Official Journal of the American College of …, 2009 | 242 | 2009 |
| Sjögren's Syndrome Disease Damage Index and disease activity index: scoring systems for the assessment of disease damage and disease activity in Sjögren's syndrome, derived … C Vitali, G Palombi, C Baldini, M Benucci, S Bombardieri, M Covelli, ... Arthritis & Rheumatism: Official Journal of the American College of …, 2007 | 238 | 2007 |
| Positive selection in autoimmunity: abnormal immune responses to a bacterial dnaJ antigenic determinant in patients with early rheumatoid arthritis S Albani, EC Keystone, JL Nelson, WER Ollier, A La Cava, ... Nature medicine 1 (5), 448-452, 1995 | 233 | 1995 |
| Tocilizumab for treatment of severe COVID-19 patients: preliminary results from SMAtteo COvid19 REgistry (SMACORE) M Colaneri, L Bogliolo, P Valsecchi, P Sacchi, V Zuccaro, F Brandolino, ... Microorganisms 8 (5), 695, 2020 | 230 | 2020 |
| Autoantibody profile in rheumatoid arthritis during long-term infliximab treatment F Bobbio-Pallavicini, C Alpini, R Caporali, S Avalle, S Bugatti, ... Arthritis Res Ther 6, 1-9, 2004 | 230 | 2004 |
| Rituximab versus tocilizumab in anti-TNF inadequate responder patients with rheumatoid arthritis (R4RA): 16-week outcomes of a stratified, biopsy-driven, multicentre, open … F Humby, P Durez, MH Buch, MJ Lewis, H Rizvi, F Rivellese, A Nerviani, ... The Lancet 397 (10271), 305-317, 2021 | 226 | 2021 |
| Risk factors for a first thrombotic event in antiphospholipid antibody carriers: a prospective multicentre follow-up study A Ruffatti, T Del Ross, M Ciprian, MT Bertero, S Salvatore, S Scarpato, ... Annals of the rheumatic diseases 70 (6), 1083-1086, 2011 | 218 | 2011 |
Mariagrazia UguccioniInstitute for Research in BiomedicineVerified email at irb.usi.ch
